Donor cell leukemia: Insight into cancer stem cells and the stem cell niche

Catherine M. Flynn, Dan S. Kaufman

Research output: Contribution to journalReview articlepeer-review

121 Scopus citations


Donor cell leukemia (DCL) is a rare complication of hematopoietic cell transplantation (HCT). Its incidence has been reported between 0.12% and 5%, although the majority of cases are anecdotal. The mechanisms of leukemogenesis in DCL may be distinct from other types of leukemia. Possible causes of DCL include oncogenic alteration or premature aging of transplanted donor cells in an immunosuppressed person. Although many studies have recently better characterized leukemic stem cells, it is important to also consider that both intrinsic cell factors and external signals from the hematopoietic microenvironment govern the developmental fate of hematopoietic stem cells (HSCs). Therefore, in cases of DCL, alteration of the microenvironment after HCT may increase the likelihood that some progeny of normal HSCs become leukemic. This complex intercommunication between cells, growth factors, and cytokines in the hematopoietic microenvironment are critical to balance HSC self-renewal, proliferation, and differentiation. However, this homeostasis is likely perturbed in the development of DCL, allowing unique insight into the stimuli that regulate normal and potentially abnormal hematopoietic development. In this article, we discuss the possible pathogenesis of DCL, its association with stem cells, and its likely dependence on a less-supportive stem cell niche.

Original languageEnglish (US)
Pages (from-to)2688-2692
Number of pages5
Issue number7
StatePublished - Apr 1 2007


Dive into the research topics of 'Donor cell leukemia: Insight into cancer stem cells and the stem cell niche'. Together they form a unique fingerprint.

Cite this